Hedi Harizi

2.7k total citations
38 papers, 2.2k citations indexed

About

Hedi Harizi is a scholar working on Immunology, Pharmacology and Infectious Diseases. According to data from OpenAlex, Hedi Harizi has authored 38 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Immunology, 13 papers in Pharmacology and 10 papers in Infectious Diseases. Recurrent topics in Hedi Harizi's work include Inflammatory mediators and NSAID effects (13 papers), Immune Response and Inflammation (12 papers) and Tuberculosis Research and Epidemiology (10 papers). Hedi Harizi is often cited by papers focused on Inflammatory mediators and NSAID effects (13 papers), Immune Response and Inflammation (12 papers) and Tuberculosis Research and Epidemiology (10 papers). Hedi Harizi collaborates with scholars based in Tunisia, France and Morocco. Hedi Harizi's co-authors include N. Gualde, Norbert Gualde, Jean‐Benoît Corcuff, M. Juzan, Jean‐François Moreau, Christophe F. Grosset, Vincent Pitard, Jalel Boukadida, Walid Ben-Selma and Véronique De Smedt‐Peyrusse and has published in prestigious journals such as The Journal of Immunology, Journal of Neurochemistry and Journal of Leukocyte Biology.

In The Last Decade

Hedi Harizi

37 papers receiving 2.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hedi Harizi Tunisia 22 848 520 441 250 231 38 2.2k
Cláudio Canetti Brazil 29 1.0k 1.2× 828 1.6× 315 0.7× 387 1.5× 136 0.6× 55 2.8k
Marc Pouliot Canada 29 860 1.0× 914 1.8× 395 0.9× 193 0.8× 71 0.3× 62 2.6k
Myungsoo Joo South Korea 31 697 0.8× 1.5k 2.9× 234 0.5× 241 1.0× 306 1.3× 103 3.3k
N. Gualde France 23 906 1.1× 574 1.1× 429 1.0× 226 0.9× 77 0.3× 80 2.3k
S A Gregory United States 17 519 0.6× 587 1.1× 495 1.1× 153 0.6× 185 0.8× 22 2.2k
F. Stephen Laroux United States 29 1.0k 1.2× 1.1k 2.1× 162 0.4× 270 1.1× 86 0.4× 44 3.1k
Kei Yamamoto Japan 25 379 0.4× 1.2k 2.2× 330 0.7× 143 0.6× 82 0.4× 41 2.4k
Elisabetta Profumo Italy 38 782 0.9× 1.3k 2.5× 160 0.4× 300 1.2× 415 1.8× 99 4.3k
David G. Besselsen United States 32 341 0.4× 1.2k 2.3× 209 0.5× 330 1.3× 414 1.8× 83 3.0k
Yong Kyoo Shin South Korea 26 429 0.5× 798 1.5× 203 0.5× 278 1.1× 129 0.6× 78 2.1k

Countries citing papers authored by Hedi Harizi

Since Specialization
Citations

This map shows the geographic impact of Hedi Harizi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hedi Harizi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hedi Harizi more than expected).

Fields of papers citing papers by Hedi Harizi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hedi Harizi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hedi Harizi. The network helps show where Hedi Harizi may publish in the future.

Co-authorship network of co-authors of Hedi Harizi

This figure shows the co-authorship network connecting the top 25 collaborators of Hedi Harizi. A scholar is included among the top collaborators of Hedi Harizi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hedi Harizi. Hedi Harizi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mastouri, Maha, et al.. (2024). In vitro immunotoxicity effects of carbendazim were inhibited by n-acetylcysteine in microglial BV-2 cells. Toxicology in Vitro. 97. 105812–105812. 3 indexed citations
2.
Galbiati, Valentina, et al.. (2023). In Vitro Effects of Cypermethrin and Glyphosate on LPS-Induced Immune Cell Activation. Life. 14(1). 62–62.
3.
Gabbouj, Sallouha, et al.. (2019). Contribution of Nitric oxide synthase 3 genetic variants to nasopharyngeal carcinoma risk and progression in a Tunisian population. European Archives of Oto-Rhino-Laryngology. 276(4). 1231–1239. 6 indexed citations
4.
Harizi, Hedi. (2015). Epigenetic Regulations of Inflammatory Cyclooxygenase‐Derived Prostanoids: Molecular Basis and Pathophysiological Consequences. Mediators of Inflammation. 2015(1). 841097–841097. 13 indexed citations
5.
Harizi, Hedi. (2013). Reciprocal crosstalk between dendritic cells and natural killer cells under the effects of PGE2 in immunity and immunopathology. Cellular and Molecular Immunology. 10(3). 213–221. 63 indexed citations
6.
Harizi, Hedi. (2013). The Immunobiology of Prostanoid Receptor Signaling in Connecting Innate and Adaptive Immunity. BioMed Research International. 2013. 1–10. 31 indexed citations
7.
Ben-Selma, Walid, et al.. (2012). Age- and gender-specific effects on NRAMP1 gene polymorphisms and risk of the development of active tuberculosis in Tunisian populations. International Journal of Infectious Diseases. 16(7). e543–e550. 20 indexed citations
8.
Ben-Selma, Walid, et al.. (2011). Interferon Gamma +874T/A Polymorphism Is Associated with Susceptibility to Active Pulmonary Tuberculosis Development in Tunisian Patients. DNA and Cell Biology. 30(6). 379–387. 31 indexed citations
9.
Ben-Selma, Walid, et al.. (2011). Polymorphisms in the RANTES Gene Increase Susceptibility to Active Tuberculosis in Tunisia. DNA and Cell Biology. 30(10). 789–800. 16 indexed citations
10.
Ben-Selma, Walid, Hedi Harizi, & Jalel Boukadida. (2011). Association of TNF-α and IL-10 polymorphisms with tuberculosis in Tunisian populations. Microbes and Infection. 13(10). 837–843. 39 indexed citations
11.
Ben-Selma, Walid, et al.. (2011). IL-10R1 S138G loss-of-function polymorphism is associated with extrapulmonary tuberculosis risk development in Tunisia. Molecular Biology Reports. 39(1). 51–56. 9 indexed citations
12.
Harizi, Hedi, Ilef Limem, & N. Gualde. (2010). CD40 engagement on dendritic cells induces cyclooxygenase‐2 and EP2 receptor via p38 and ERK MAPKs. Immunology and Cell Biology. 89(2). 275–282. 15 indexed citations
13.
Harizi, Hedi, et al.. (2010). Inhibition of proinflammatory macrophage responses and lymphocyte proliferation in vitro by ethyl acetate leaf extract from Daphne gnidium. Cellular Immunology. 267(2). 94–101. 27 indexed citations
14.
Limem, Ilef, Hedi Harizi, Kamel Ghedira, & Leila Chekir‐Ghedira. (2010). Leaf extracts fromPhlomis crinitaCav. subs.mauritanicaMunby affect immune cell functionsin vitro. Immunopharmacology and Immunotoxicology. 33(2). 309–314. 17 indexed citations
15.
Harizi, Hedi, Jean‐Benoît Corcuff, & N. Gualde. (2008). Arachidonic-acid-derived eicosanoids: roles in biology and immunopathology. Trends in Molecular Medicine. 14(10). 461–469. 470 indexed citations
16.
Harizi, Hedi, et al.. (2008). Inter-strain differences in glucocorticoid and mineralocorticoid effects on macrophage and lymphocyte functions in mice. Journal of Neuroimmunology. 204(1-2). 38–42. 8 indexed citations
18.
Harizi, Hedi, M. Juzan, Jean‐François Moreau, & Norbert Gualde. (2003). Prostaglandins Inhibit 5-Lipoxygenase-Activating Protein Expression and Leukotriene B4 Production from Dendritic Cells Via an IL-10-Dependent Mechanism. The Journal of Immunology. 170(1). 139–146. 68 indexed citations
19.
Harizi, Hedi & N. Gualde. (2002). Dendritic cells produce eicosanoids, which modulate generation and functions of antigen-presenting cells. Prostaglandins Leukotrienes and Essential Fatty Acids. 66(5-6). 459–466. 36 indexed citations
20.
Harizi, Hedi, M. Juzan, Christophe F. Grosset, M Rashedi, & N. Gualde. (2001). Dendritic Cells Issued in Vitro from Bone Marrow Produce PGE2 That Contributes to the Immunomodulation Induced by Antigen-Presenting Cells. Cellular Immunology. 209(1). 19–28. 95 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026